See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Trip.com Group Limited Sponsored ADR (TCOM) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Trip.com Group Limited Sponsored ADR (TCOM) - free report >>
Image: Bigstock
Best Momentum Stocks to Buy for October 7th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, October 7th:
Montauk Renewables, Inc. (MNTK - Free Report) : This biogas focused renewable energy company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.3% over the last 60 days.
Montauk Renewables, Inc. Price and Consensus
Montauk Renewables, Inc. price-consensus-chart | Montauk Renewables, Inc. Quote
Montauk’s shares gained 44.8% over the last three months compared with the S&P 500’s decline of 3.4%. The company possesses a Momentum Score of A.
Montauk Renewables, Inc. Price
Montauk Renewables, Inc. price | Montauk Renewables, Inc. Quote
Larimar Therapeutics, Inc. (LRMR - Free Report) : This clinical-stage biotechnology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 23.3% over the last 60 days.
Larimar Therapeutics, Inc. Price and Consensus
Larimar Therapeutics, Inc. price-consensus-chart | Larimar Therapeutics, Inc. Quote
Larimar’s shares gained 65.6% over the last three months compared with the S&P 500’s decline of 3.4%. The company possesses a Momentum Score of A.
Larimar Therapeutics, Inc. Price
Larimar Therapeutics, Inc. price | Larimar Therapeutics, Inc. Quote
Trip.com Group Limited (TCOM - Free Report) : This travel service provider for the leisure and recreation industry has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 46.2% over the last 60 days.
Trip.com Group Limited Sponsored ADR Price and Consensus
Trip.com Group Limited Sponsored ADR price-consensus-chart | Trip.com Group Limited Sponsored ADR Quote
Trip.com’s shares gained 10.6% over the last three months compared with the S&P 500’s decline of 3.4%. The company possesses a Momentum Score of B.
Trip.com Group Limited Sponsored ADR Price
Trip.com Group Limited Sponsored ADR price | Trip.com Group Limited Sponsored ADR Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.